Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Basking Ridge. Study-provided care at no cost to qualified participants.
Access bladder cancer specialists in Basking Ridge at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bladder cancer treatment provided free
The purpose of this study is to find out the effectiveness of pembrolizumab in combination with BCG as a first line therapy for participants with high grade T1 bladder cancer who are at "high risk" for BCG alone to be ineffective and are seeking an alternative treatment option to radical cystectomy. There is biologic rationale for combining pembrolizumab and BCG as two distinct immunotherapies with possible additive or synergistic activity in urothelial cancer. The combination of pembrolizumab w
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this bladder cancer clinical trial in Basking Ridge, NJ
If you're searching for bladder cancer treatment options in Basking Ridge, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Basking Ridge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.